Literature DB >> 1884891

Autoantibodies and genetic factors associated with the development of type 1 (insulin-dependent) diabetes mellitus in first degree relatives of diabetic patients.

C Thivolet1, B Beaufrère, L Geburher, P Chatelain, J Orgiazzi, R François.   

Abstract

Factors associated with diabetes onset were analysed for their predictive value in 708 first-degree relatives of Type 1 (insulin-dependent) diabetic patients including 374 parents and 308 siblings of Type 1 diabetic patients. Relatives were prospectively followed for 2,304 subject years with blood samples for specific autoantibody evaluation. Islet cell cytoplasmic autoantibody titres were quantified in Juvenile Diabetes Foundation units with a threshold of positivity of 5 units. Insulin autoantibodies were determined using Tyr-A14 iodinated human insulin. HLA typing was performed in 92% of the relatives. During the time of study, 17 of 646 (2.6%) relatives showed islet cell antibodies. During follow-up, eight relatives developed diabetes, including six with high islet cell antibody titre. Taking titres above 20 units increased the positive predictive value from 35% to 75% whereas the presence of insulin autoantibodies did not increase the positive predictive value for the disease. Analysis of metabolic profiles months before the onset of diabetes by either oral or intravenous glucose loads, indicated a considerable level of heterogeneity with relatives with a high islet cell antibody titre who rapidly developed insulin-dependent diabetes, whereas other remained insulin-independent during the same observation period despite comparable titres. This study clearly indicates that initial islet cell antibody titre is not sufficient to predict individual outcome. Follow-up samples are clearly needed to monitor progression of the disease. Few relatives with persistent immunologic positivity progress to clinical Type 1 diabetes, suggesting that non-progressive and sub-clinical Beta-cell dysfunction is common.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1884891     DOI: 10.1007/bf00418274

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  28 in total

1.  Analysis of metabolic progression to type I diabetes in ICA+ relatives of patients with type I diabetes.

Authors:  D Bleich; R A Jackson; J S Soeldner; G S Eisenbarth
Journal:  Diabetes Care       Date:  1990-02       Impact factor: 19.112

2.  Islet cell and insulin autoantibodies in subjects at high risk for development of type 1 (insulin-dependent) diabetes mellitus: the Lyon family study.

Authors:  C Thivolet; B Beaufrére; H Bétuel; L Gebuhrer; P Chatelain; A Durand; J Tourniaire; R François
Journal:  Diabetologia       Date:  1988-10       Impact factor: 10.122

3.  Nonprogression of subclinical beta-cell dysfunction among first-degree relatives of IDDM patients. 5-yr follow-up of the Seattle Family Study.

Authors:  D K McCulloch; L J Klaff; S E Kahn; S L Schoenfeld; C J Greenbaum; R S Mauseth; E A Benson; G T Nepom; L Shewey; J P Palmer
Journal:  Diabetes       Date:  1990-05       Impact factor: 9.461

4.  Islet-cell antibodies as predictors of the later development of type 1 (insulin-dependent) diabetes. A study in identical twins.

Authors:  C Johnston; B A Millward; P Hoskins; R D Leslie; G F Bottazzo; D A Pyke
Journal:  Diabetologia       Date:  1989-06       Impact factor: 10.122

5.  Fluctuating islet-cell autoimmunity in unaffected relatives of patients with insulin-dependent diabetes.

Authors:  K M Spencer; A Tarn; B M Dean; J Lister; G F Bottazzo
Journal:  Lancet       Date:  1984-04-07       Impact factor: 79.321

6.  Autoimmunity to insulin, beta cell dysfunction, and development of insulin-dependent diabetes mellitus.

Authors:  S Srikanta; A T Ricker; D K McCulloch; J S Soeldner; G S Eisenbarth; J P Palmer
Journal:  Diabetes       Date:  1986-02       Impact factor: 9.461

7.  Breeding of a non-obese, diabetic strain of mice.

Authors:  S Makino; K Kunimoto; Y Muraoka; Y Mizushima; K Katagiri; Y Tochino
Journal:  Jikken Dobutsu       Date:  1980-01

8.  Factors associated with early remission of type I diabetes in children treated with cyclosporine.

Authors:  P F Bougneres; J C Carel; L Castano; C Boitard; J P Gardin; P Landais; J Hors; M J Mihatsch; M Paillard; J L Chaussain
Journal:  N Engl J Med       Date:  1988-03-17       Impact factor: 91.245

9.  Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group.

Authors: 
Journal:  Diabetes       Date:  1979-12       Impact factor: 9.461

10.  Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes.

Authors:  E Bonifacio; P J Bingley; M Shattock; B M Dean; D Dunger; E A Gale; G F Bottazzo
Journal:  Lancet       Date:  1990-01-20       Impact factor: 79.321

View more
  8 in total

1.  Early seroconversion and rapidly increasing autoantibody concentrations predict prepubertal manifestation of type 1 diabetes in children at genetic risk.

Authors:  V Parikka; K Näntö-Salonen; M Saarinen; T Simell; J Ilonen; H Hyöty; R Veijola; M Knip; O Simell
Journal:  Diabetologia       Date:  2012-03-23       Impact factor: 10.122

2.  Natural history of preclinical IDDM in high risk siblings. Childhood Diabetes in Finland Study Group.

Authors:  M Knip; P Vähäsalo; J Karjalainen; R Lounamaa; H K Akerblom
Journal:  Diabetologia       Date:  1994-04       Impact factor: 10.122

3.  Islet cell antibodies in normal French schoolchildren.

Authors:  C Lévy-Marchal; J Tichet; I Fajardy; X F Gu; F Dubois; P Czernichow
Journal:  Diabetologia       Date:  1992-06       Impact factor: 10.122

4.  Glutamic acid decarboxylase (GAD) autoantibodies are additional predictive markers of type 1 (insulin-dependent) diabetes mellitus in high risk individuals.

Authors:  C H Thivolet; M Tappaz; A Durand; J Petersen; A Stefanutti; P Chatelain; B Vialettes; W Scherbaum; J Orgiazzi
Journal:  Diabetologia       Date:  1992-06       Impact factor: 10.122

5.  Anti-37kDa antibodies are associated with the development of IDDM in individuals with islet cell antibodies.

Authors:  J C Ongagna; C Levy-Marchal
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

6.  Importance of persistent cellular and humoral immune changes before diabetes develops: prospective study of identical twins.

Authors:  R Y Tun; M Peakman; L Alviggi; M J Hussain; S S Lo; M Shattock; D A Pyke; G F Bottazzo; D Vergani; R D Leslie
Journal:  BMJ       Date:  1994-04-23

7.  Life table analysis of the risk of type 1 (insulin-dependent) diabetes mellitus in siblings according to islet cell antibodies and HLA markers. An 8-year prospective study.

Authors:  I Deschamps; C Boitard; J Hors; M Busson; A Marcelli-Barge; A Mogenet; J J Robert
Journal:  Diabetologia       Date:  1992-10       Impact factor: 10.122

8.  Molecular biology of IDDM.

Authors:  A Lernmark
Journal:  Diabetologia       Date:  1994-09       Impact factor: 10.122

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.